Binex Co., Ltd.
↗Busan, South Korea
Binex Co., Ltd. is a prominent South Korean biopharmaceutical company and a leading Contract Development and Manufacturing Organization (CDMO). Established in 1957, the company has transitioned from a traditional chemical pharmaceutical manufacturer into a global biologics powerhouse. It provides a comprehensive range of services including cell line development, process development, and cGMP manufacturing for drug substances and drug products.
The company operates state-of-the-art facilities in Songdo (Incheon) and Osong (Chungbuk), with a total mammalian cell culture capacity exceeding 11,000 liters. Binex is recognized as a critical partner for major Korean biotech firms like Celltrion and Genexine, and it recently achieved a major milestone by securing U.S. FDA cGMP clearance for large-scale biologics production in early 2024.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Revenue:$117M (TTM 2025)
Founded:1957
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:Kwangdong Pharmaceutical, Binex Holdings
STOCK
Exchange:KOSDAQ
Ticker:053030
Market Cap:$333M
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (CDMO for Celltrion's biosimilars)
Modalities:mAb, Biosimilars, Vaccines (DNA/Mucosal), ADC, Small molecule, Probiotics
Active Trials:3
Trial Phases:Phase 1: 1 | Phase 2: 1 | Phase 3: 1
FDA Approvals:1
EMA Approvals:1
CORPORATE STRUCTURE
Subsidiaries:Bigen Co., Ltd., Genemed Co., Ltd.
Key Partnerships:Celltrion (Biosimilar manufacturing), Genexine (COVID-19 vaccine development), Kyongbo Pharmaceutical (ADC CDMO collaboration), GI Innovation (Strategic development partnership)
COMPETITION
Position:Challenger
Competitors:Samsung Biologics, ST Pharm, SK bioscience, Lonza, WuXi Biologics
LEADERSHIP
Key Executives:
Won-Seok Kim - CEO
Hyeok-Jong Lee - President
Board Members:Won-Seok Kim, Hyeok-Jong Lee, Ji-young Kim (Director)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Binex Co., Ltd.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.